Prascend (pergolide mesylate), dopamine receptor agonist, is the first and only FDA-approved treatment for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each tablet contains 1 mg of pergolide mesylate. For oral use in horses.
Prascend (pergolide mesylate), 1 mg tab
Prescription items are non-returnable
$12 rebate on 60 count box!
$30 rebate on 160 count box!
Go to www.boehringeringelheimequinerebates.com, submit a copy of the invoice, and get cash back.
Good for products purchased from a veterinarian between Feb 1, 2020 - Feb 28, 2021. Rebate request must be received on or before April 1, 2021.